Prevention of premature labor by 17 alpha-hydroxyprogesterone caproate. 1985

M Yemini, and R Borenstein, and E Dreazen, and Z Apelman, and B M Mogilner, and I Kessler, and M Lancet

Eighty pregnant women at high risk of giving birth prematurely were divided randomly into two groups. Treatment with either 17 alpha-hydroxyprogesterone caproate, 250 mg by intramuscular injection once a week, or a placebo was given in a double-blind fashion. Imminent premature labor occurred in 29.0% of the treated group and in 59.4% of the control group (p less than 0.025). The rate of premature deliveries was also significantly lower in the treated group (16.1%) than in the control group (37.82%) (p less than 0.05). There were no cases of perinatal death or fetal malformations in either group. The mean birth weight of all infants of the treated group was significantly higher than in those of the control group (3111.9 +/- 905 gm versus 2680 +/- 813.4 gm, p less than 0.05). The results support treatment with progesterone caproate for the prevention of premature labor.

UI MeSH Term Description Entries
D007226 Infant Mortality Postnatal deaths from BIRTH to 365 days after birth in a given population. Postneonatal mortality represents deaths between 28 days and 365 days after birth (as defined by National Center for Health Statistics). Neonatal mortality represents deaths from birth to 27 days after birth. Neonatal Mortality,Mortality, Infant,Postneonatal Mortality,Infant Mortalities,Mortalities, Infant,Mortalities, Neonatal,Mortalities, Postneonatal,Mortality, Neonatal,Mortality, Postneonatal,Neonatal Mortalities,Postneonatal Mortalities
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007234 Infant, Premature A human infant born before 37 weeks of GESTATION. Neonatal Prematurity,Premature Infants,Preterm Infants,Infant, Preterm,Infants, Premature,Infants, Preterm,Premature Infant,Prematurity, Neonatal,Preterm Infant
D007752 Obstetric Labor, Premature Onset of OBSTETRIC LABOR before term (TERM BIRTH) but usually after the FETUS has become viable. In humans, it occurs sometime during the 29th through 38th week of PREGNANCY. TOCOLYSIS inhibits premature labor and can prevent the BIRTH of premature infants (INFANT, PREMATURE). Preterm Labor,Labor, Premature,Premature Labor,Premature Obstetric Labor,Labor, Premature Obstetric,Labor, Preterm
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D001724 Birth Weight The mass or quantity of heaviness of an individual at BIRTH. It is expressed by units of pounds or kilograms. Birthweight,Birth Weights,Birthweights,Weight, Birth,Weights, Birth
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M Yemini, and R Borenstein, and E Dreazen, and Z Apelman, and B M Mogilner, and I Kessler, and M Lancet
December 1979, IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans,
M Yemini, and R Borenstein, and E Dreazen, and Z Apelman, and B M Mogilner, and I Kessler, and M Lancet
December 1964, Ceskoslovenska farmacie,
M Yemini, and R Borenstein, and E Dreazen, and Z Apelman, and B M Mogilner, and I Kessler, and M Lancet
June 2003, The New England journal of medicine,
M Yemini, and R Borenstein, and E Dreazen, and Z Apelman, and B M Mogilner, and I Kessler, and M Lancet
September 2003, The New England journal of medicine,
M Yemini, and R Borenstein, and E Dreazen, and Z Apelman, and B M Mogilner, and I Kessler, and M Lancet
July 1958, Annals of the New York Academy of Sciences,
M Yemini, and R Borenstein, and E Dreazen, and Z Apelman, and B M Mogilner, and I Kessler, and M Lancet
October 1975, The New England journal of medicine,
M Yemini, and R Borenstein, and E Dreazen, and Z Apelman, and B M Mogilner, and I Kessler, and M Lancet
October 1980, American journal of obstetrics and gynecology,
M Yemini, and R Borenstein, and E Dreazen, and Z Apelman, and B M Mogilner, and I Kessler, and M Lancet
August 2018, American journal of obstetrics and gynecology,
M Yemini, and R Borenstein, and E Dreazen, and Z Apelman, and B M Mogilner, and I Kessler, and M Lancet
February 2009, The Journal of reproductive medicine,
M Yemini, and R Borenstein, and E Dreazen, and Z Apelman, and B M Mogilner, and I Kessler, and M Lancet
February 2018, American journal of obstetrics and gynecology,
Copied contents to your clipboard!